Furthermore, to investigate the impact of BHLHE40 in the TME on pancreatic cancer survival, we organized an analysis of the potential linkage of BHLHE40 in various immune cell subpopulations on pancreatic cancer prognosis. Here, BHLHE40 is linked to familial pancreatic carcinoma.